Trials / Terminated
TerminatedNCT03691415
Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea
Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Post Marketing Surveillance Study in Korea
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this PMS study is to evaluate the safety and effectiveness of BELKYRA Inj. used according to the dose specified in the instructions for use, for the treatment of patients with SM fullness due to SMF, through active investigation under routine clinical practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BELKYRA Inj. | Patient will be administered BELKYRA Inj. at least once and the interval between treatments not less than 1 month apart. |
Timeline
- Start date
- 2018-09-07
- Primary completion
- 2020-04-14
- Completion
- 2020-04-14
- First posted
- 2018-10-01
- Last updated
- 2020-12-07
Locations
4 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03691415. Inclusion in this directory is not an endorsement.